Study of VVN461 eye drops for anterior uveitis
Part of Eyes & vision, Immune system & allergy clinical trials.
This study tests an eye drop (VVN461) for a type of eye inflammation called anterior uveitis. It may help reduce inflammation and symptoms in people who have a flare-up in one eye.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have non-infectious anterior uveitis (eye inflammation not caused by an infection) that is currently active in one eye only.
- Your eye inflammation is moderate to severe (grade 2+ or 3+ on the SUN scale) and you also have some cells floating in the front of your eye (grade 1 or higher).
- Your eye does not have the most severe inflammation (grade 4+) or a collection of pus (hypopyon).
- You do not have inflammation in the middle or back of the eye (intermediate, posterior, or panuveitis) in either eye.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new eye drop (tacrolimus) to treat non-infectious anterior uveitis, an inflammation in the front part of the eye. It may help reduce the need for steroid eye drops.
This trial tests a new drug called FXS5626 to treat non-infectious uveitis—inflammation inside the eye that doesn't come from infection. The study looks at whether this drug can reduce eye inflammation and improve vision in people whose condition isn't controlled with steroid eye drops and oral steroids alone.
This study tests a new eye drop (5% VVN001) to treat dry eye disease that hasn't improved enough with artificial tears. It may help people with moderate-to-severe dry eye and low tear production.
This study follows adults with non-infectious uveitis (intermediate, posterior, or pan-uveitis) to better understand inflammation activity and treatment needs. It also follows adults having planned eye surgery (like cataract or vitreoretinal surgery) to compare groups.
This trial tests antiviral medications (pills and eye drops) to treat and prevent a viral eye inflammation caused by cytomegalovirus (CMV). The study has two parts: one for newly diagnosed active inflammation, and another to prevent flare-ups in people who've already had CMV eye inflammation.
This trial looks at how often inflammatory flare-ups happen in patients with a type of eye inflammation called posterior uveitis. It focuses on people who have been treated with a fluocinolone acetonide implant, a tiny device placed in the eye that releases medicine over time, and aims to understand how well it controls inflammation.
Hear when a new Non-infectious Anterior Uveitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.